Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

Kidney International

Volumn 61, Issue 3, 2002, Pages 1086-1097

  Schrier, Robert W ^a   Estacio, Raymond O ^a   Esler, Anne ^a   Mehler, Philip ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Hypertensive therapy; Microvascular complications; Type 2 diabetes

Indexed keywords

ALBUMIN; CREATININE; ENALAPRIL; NISOLDIPINE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORBIDITY; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RANDOMIZATION; STROKE; URINARY EXCRETION;

EID: 0036190137     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00213.x     Document Type: Conference Paper

References (44)

1. Incidence and prevalence of ESRD
2. Diabetic retinopathy
3. Increased incidence of retinopathy in diabetes with elevated blood pressure
4. High blood pressure as risk factor in diabetic retinopathy development in NIDDM patients
5. Role of risk factors in complications of diabetes mellitus
6. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension
7. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
8. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
9. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
10. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
11. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes
12. Baseline characteristics of participants in the appropriate blood pressure control in diabetes trial
13. Grading diabetic retinopathy from stereoscopic color fundus photographs. An extension of the Modified Airlie House Classification: ETDRS report number 10
14. Report and recommendations of the San Antonio conference on diabetic neuropathy
15. Microalbuminuria in diabetic renal disease
16. Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report no. 12
17. Detection, characterization, and staging of polyneuropathy assessed in diabetics
18. Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (NIDDM)
19. Effect of risk factors on exercise capacity in NIDDM
20. Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM
21. Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy
22. Associations of hypertension and complications in non-insulin-dependent diabetes mellitus
23. Clinical factors associated with urinary albumin excretion in type II diabetes
24. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM
25. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: A population study
26. Characteristics of patients with uncontrolled hypertension in the United States
27. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial
28. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients
29. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991
30. The clinical course of renal function in NIDDM patients with normo- and microalbuminuria
31. Effect of antihypertensive treatment on kidney function in diabetic nephropathy
32. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals
33. Effects of angiotensin-converting enzyme inhibition versus conventional antihypertensive therapy on the glomerular filtration rate
34. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment
35. Blood pressure and the progression of mild background diabetic retinopathy
36. Ocular factors in the incidence and progression of diabetic retinopathy
37. A cohort study of the relationship of diabetic retinopathy to blood pressure
38. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
39. Prevalence of diabetic complications in relation to risk factors
40. A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy
41. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid